| 14752 | A | 090030 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI USA | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2017-01-31 | Jan 31, 2017 | No | No | No | RX | FRESENIUS KABI USA LLC | 172e616afd6a4e9de1a1c5b0b4e171da764cd63a921d0091a9e61b56bacaae04 |
| 14753 | A | 090030 | 003 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI USA | 200MG/40ML (5MG/ML) | | [] | 2017-01-31 | Jan 31, 2017 | No | No | No | DISCN | FRESENIUS KABI USA LLC | b34e74871a666ed03f5e84e24bd9b570b888baf706c6529871e41124c4770a61 |
| 14754 | A | 207325 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | GLAND PHARMA LTD | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2017-02-10 | Feb 10, 2017 | No | No | No | RX | GLAND PHARMA LTD | e9fefbe5f4c6d9894a132e02ed1d410c61a678e38baec67dafe55c1cf965d69b |
| 14755 | A | 207385 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | GLAND PHARMA LTD | 50MG/VIAL | AP | ["AP"] | 2017-05-23 | May 23, 2017 | No | No | No | RX | GLAND PHARMA LTD | 55d131fb19af5172fc7a7042a615b234db28f64d085b36a6e22d1e3939ad36f9 |
| 14756 | A | 207325 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | GLAND PHARMA LTD | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2017-02-10 | Feb 10, 2017 | No | No | No | RX | GLAND PHARMA LTD | 0bf1f35126e627d90ba20db9b0e01c3a460ebd7d92ee512337ef7c21fb51794c |
| 14757 | A | 207385 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | GLAND PHARMA LTD | 100MG/VIAL | AP | ["AP"] | 2017-05-23 | May 23, 2017 | No | No | No | RX | GLAND PHARMA LTD | dc852a7566e736d9f93d9911d410131606ed31d58a78eb001629ef4e543313cb |
| 14758 | A | 207325 | 003 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | GLAND PHARMA LTD | 200MG/40ML (5MG/ML) | | [] | 2017-10-18 | Oct 18, 2017 | No | No | No | DISCN | GLAND PHARMA LTD | 59b22af1f33982b1bac65195e5914524a294f09bb81d903ed274f2334b29d086 |
| 14759 | A | 078815 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | HOSPIRA INC | 50MG/VIAL | | [] | 2009-09-30 | Sep 30, 2009 | No | No | No | DISCN | HOSPIRA INC | bd189425415d42357e4e82164579d18b22e8d1bd0240f56008e6db97ae8b80b7 |
| 14760 | A | 078815 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | HOSPIRA INC | 100MG/VIAL | | [] | 2009-09-30 | Sep 30, 2009 | No | No | No | DISCN | HOSPIRA INC | 85b3417677abe6b9130ee140fc41315c6119f9ed53a7ef27826186aa508f533c |
| 14761 | A | 078813 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | HOSPIRA WORLDWIDE | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2009-08-07 | Aug 7, 2009 | No | No | No | RX | HOSPIRA WORLDWIDE PTY | d3fbc5f719ca796a41fd5482af4fd89bda91b64b752ac5a9934a4d454d716f10 |
| 14762 | A | 078813 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | HOSPIRA WORLDWIDE | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2009-08-07 | Aug 7, 2009 | No | No | No | RX | HOSPIRA WORLDWIDE PTY | 0c2250870b47debaa2787908f64b66bacd6c4a282d2fddc96f162a4ec93002ed |
| 14763 | A | 207562 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | INGENUS PHARMS LLC | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2018-10-16 | Oct 16, 2018 | No | No | No | RX | INGENUS PHARMACEUTICALS LLC | 6159299cb4a520102e6256d9c15f3887f9e9eca602a6d561e09ea2b2bbb0c7ad |
| 14764 | A | 207562 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | INGENUS PHARMS LLC | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2018-10-16 | Oct 16, 2018 | No | No | No | RX | INGENUS PHARMACEUTICALS LLC | ef83b8a2cab7eb99d4caa3bb4eee575a15ed0ea6540751d60396b9c713be34cd |
| 14765 | A | 203869 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | JIANGSU HENGRUI MED | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2014-06-18 | Jun 18, 2014 | No | No | No | RX | JIANGSU HENGRUI MEDICINE CO LTD | 63ff0deff03ff9ecc6fd37e3ea1d6a15f8220b4c1ac659d9c97c1b91b875a414 |
| 14766 | A | 203869 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | JIANGSU HENGRUI MED | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2014-06-18 | Jun 18, 2014 | No | No | No | RX | JIANGSU HENGRUI MEDICINE CO LTD | d01f334649e5e6226a886fa7da091926698782c1430e53cb085b9dd72614cb85 |
| 14767 | A | 091358 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | MYLAN LABS LTD | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2012-08-07 | Aug 7, 2012 | No | No | No | RX | MYLAN LABORATORIES LTD | 43a5187fff6dfea72f34fb0afd87441a091c13cad5ccf3eb5de95bd85aca23f1 |
| 14768 | A | 200979 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | MYLAN LABS LTD | 50MG/VIAL | | [] | 2012-08-08 | Aug 8, 2012 | No | No | No | DISCN | MYLAN LABORATORIES LTD | b1f94289d6329cbc874cf0117a57da26b006e186c5c477f572ca30b71737beae |
| 14769 | A | 091358 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | MYLAN LABS LTD | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2012-08-07 | Aug 7, 2012 | No | No | No | RX | MYLAN LABORATORIES LTD | ce8c28719d033bb5ad98fb98ff92986ca5320eb1f7726e1c3a2094ce05242f73 |
| 14770 | A | 200979 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | MYLAN LABS LTD | 100MG/VIAL | | [] | 2012-08-08 | Aug 8, 2012 | No | No | No | DISCN | MYLAN LABORATORIES LTD | 29368878346441cfe317168ea7ee0650a3438b0c83ac1dbe11246d0ee1c2d9f5 |
| 14771 | A | 091358 | 003 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | MYLAN LABS LTD | 200MG/40ML (5MG/ML) | | [] | 2017-11-14 | Nov 14, 2017 | No | No | No | DISCN | MYLAN LABORATORIES LTD | 158d11f26706c5b7e596020f3adde75809f1b91f7484dbdcd136edc5d75561de |
| 14772 | A | 204368 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | QILU | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2016-06-07 | Jun 7, 2016 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | 9a965ac423807782c82a81321134313cdfa29362d20554b264788752b7a9924c |
| 14773 | A | 204616 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | QILU | 50MG/VIAL | AP | ["AP"] | 2016-05-11 | May 11, 2016 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | ad619cac995ac12823605c6a5a6273564e6d51f95429a08175f86b408fdd44f4 |
| 14774 | A | 204368 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | QILU | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2016-06-07 | Jun 7, 2016 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | f377de7caee933d4ef4a16955b07bf9222380ef40b022a35dff4cb2806b95be5 |
| 14775 | A | 204616 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | QILU | 100MG/VIAL | AP | ["AP"] | 2016-05-11 | May 11, 2016 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | 81bf2a2415c99bf98844c43bc67351211b16269359cb32e5e9a3edfef4bde395 |
| 14776 | A | 204368 | 003 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | QILU | 200MG/40ML (5MG/ML) | | [] | 2016-06-07 | Jun 7, 2016 | No | No | Yes | RX | QILU PHARMACEUTICAL CO LTD | c1bbeb96d1cc9665ca9e7829eb2f7b8cad76242915451d6edf1d6ec99b2c17f1 |
| 14777 | A | 078817 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SANDOZ | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2011-01-24 | Jan 24, 2011 | No | No | No | RX | SANDOZ INC | 46869abe9d385d633f8e4ddccc79b4c0383b88f7da1d3482eabf8c27eea094f9 |
| 14778 | A | 090849 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SANDOZ | 50MG/VIAL | | [] | 2011-04-28 | Apr 28, 2011 | No | No | No | DISCN | SANDOZ INC | b9fe4a412d8b3fa0c7a437f8b55512d29a1e342dc2c4dc1d69300b0124c5e3e3 |
| 14779 | A | 078817 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SANDOZ | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2011-01-24 | Jan 24, 2011 | No | No | No | RX | SANDOZ INC | c33dfb8d3803bb68cc2f187e7ff24e16f06f09528838c2369db733f7233d5776 |
| 14780 | A | 090849 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SANDOZ | 100MG/VIAL | | [] | 2011-04-28 | Apr 28, 2011 | No | No | No | DISCN | SANDOZ INC | a75b80ec4fd0c80c8366cdc304344c1bfea05990ba6bdd576fe9a451bdcd8886 |
| 14781 | A | 078812 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SANDOZ INC | 50MG/10ML (5MG/ML) | | [] | 2009-08-07 | Aug 7, 2009 | No | No | No | DISCN | SANDOZ INC | 3cd58399e087ae7b4271891564a1a501db8454338d4ce94a886812fdc58bf567 |
| 14782 | A | 078812 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SANDOZ INC | 100MG/20ML (5MG/ML) | | [] | 2009-08-07 | Aug 7, 2009 | No | No | No | DISCN | SANDOZ INC | a07c98b9537429cbb033c6da4f02fddc70b7abfc772673ab054910cf93626dde |
| 14783 | A | 078818 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SUN PHARM | 50MG/VIAL | | [] | 2009-08-07 | Aug 7, 2009 | No | No | No | DISCN | SUN PHARMACEUTICAL INDUSTRIES LTD | a2d4313afbae85284f53ea317a7bc427893fe1dddac76264d41c670864503bf5 |
| 14784 | A | 202922 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SUN PHARM | 50MG/10ML (5MG/ML) | | [] | 2014-04-08 | Apr 8, 2014 | No | No | No | DISCN | SUN PHARMACEUTICAL INDUSTRIES LTD | 1cf158fcdf0fac26aafa722c687dcda7bad7fbeba795b7e12395ebe96c961a82 |
| 14785 | A | 078818 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SUN PHARM | 100MG/VIAL | | [] | 2009-08-07 | Aug 7, 2009 | No | No | No | DISCN | SUN PHARMACEUTICAL INDUSTRIES LTD | 5eae972341c40cff7cec9bc526985254482dca67ec46fd3150511c611fbce8e8 |
| 14786 | A | 202922 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SUN PHARM | 100MG/20ML (5MG/ML) | | [] | 2014-04-08 | Apr 8, 2014 | No | No | No | DISCN | SUN PHARMACEUTICAL INDUSTRIES LTD | f04e5acbe9915b0f0941736200d5f6191e7ae57ed0c55a6935ff9721ec0e7bef |
| 14787 | A | 202922 | 003 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | SUN PHARM | 200MG/40ML (5MG/ML) | | [] | 2019-02-15 | Feb 15, 2019 | No | No | No | DISCN | SUN PHARMACEUTICAL INDUSTRIES LTD | f51081011057f489c176060991f5a0c4c92dae92b36b1c79440b592fc0016bc6 |
| 14788 | N | 022160 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | TEVA PHARMS | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2009-08-07 | Aug 7, 2009 | No | Yes | Yes | RX | TEVA PHARMACEUTICALS USA | aa8b094c2299415f9621c95dcac9a3e56c73c41790f239c700c7f692d31e974b |
| 14789 | N | 022160 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | TEVA PHARMS | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2009-08-07 | Aug 7, 2009 | No | Yes | Yes | RX | TEVA PHARMACEUTICALS USA | 69d892a95c38be6e802d8197511097605ba7072121e45feca143873c0aeefce0 |
| 14790 | A | 204615 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | ACCORD HLTHCARE | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2021-03-15 | Mar 15, 2021 | No | No | No | RX | ACCORD HEALTHCARE INC | 94c0111cc589364a546a74801318d1e5c69ba8d120d9369cd475c9c72153072b |
| 14791 | A | 204702 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | AUROBINDO PHARMA LTD | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-11-06 | Nov 6, 2018 | No | No | No | RX | AUROBINDO PHARMA LTD | eef02458a86d8b729bd02693c1e9178fc1a249c31eed3390e8ecaad43836a1a0 |
| 14792 | A | 206396 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | CIPLA | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-09-19 | Sep 19, 2018 | No | No | No | RX | CIPLA LTD | 72207269ca7e5e1a01eb92c3dfe4a3d369408291be06120691fe6374d35e89bd |
| 14793 | A | 201533 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | DR REDDYS LABS LTD | EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) | | [] | 2016-04-21 | Apr 21, 2016 | No | No | No | DISCN | DR REDDYS LABORATORIES LTD | 7806e321ba690dbec9aad914b03a41a455226085a8f85979fd5cf68405a22b0f |
| 14794 | A | 201533 | 002 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | DR REDDYS LABS LTD | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2016-04-21 | Apr 21, 2016 | No | No | No | RX | DR REDDYS LABORATORIES LTD | 2d0df9a3d242b8d275c121574ff05c51c8d2752018c9a6fa3225152bb69d799c |
| 14795 | A | 206801 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | FRESENIUS KABI USA | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-09-19 | Sep 19, 2018 | No | No | No | RX | FRESENIUS KABI USA LLC | e20cb8a623f7dbd94189509239b55f5dcc987f9d57abad7b54ef439a376c604b |
| 14796 | A | 206802 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | FRESENIUS KABI USA | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-09-19 | Sep 19, 2018 | No | No | No | RX | FRESENIUS KABI USA LLC | 1ec37051c0809d8161c1f5412319645d8b2830d3b1e3d03664736e8e3f11860c |
| 14797 | A | 207005 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | HOSPIRA INC | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-09-19 | Sep 19, 2018 | No | No | No | RX | HOSPIRA INC | 634a8108e5557046c8993ec2ecab6a856ce1a7eb64ba0e346f938f9fe85642ec |
| 14798 | A | 207005 | 002 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | HOSPIRA INC | EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-09-19 | Sep 19, 2018 | No | No | No | RX | HOSPIRA INC | 1eaf0cb27d4598a5fb5a96a23c82be50e99e3a1d85ec14d8fd8ede144c3fa227 |
| 14799 | A | 208789 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | INGENUS PHARMS LLC | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2020-05-22 | May 22, 2020 | No | No | No | RX | INGENUS PHARMACEUTICALS LLC | e3d805564f4e613b2adb4543afd3ff4915f2f8411dd49d096d46ab183a55a006 |
| 14800 | A | 206416 | 001 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | MYLAN INSTITUTIONAL | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-09-19 | Sep 19, 2018 | No | No | No | RX | MYLAN INSTITUTIONAL LLC | e11ee0cad3c0b44ce26199811dccd9a62200e6c9ab322816a097b48750c8b26e |
| 14801 | A | 205648 | 002 | PALONOSETRON HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | PALONOSETRON HYDROCHLORIDE | QILU | EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) | AP | ["AP"] | 2018-09-19 | Sep 19, 2018 | No | No | No | RX | QILU PHARMACEUTICAL CO LTD | 731eba032e1668a5089443714bed64506eb59d8666be21716b896c9a5d0a6614 |